These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22016416)

  • 1. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.
    Molskness TA; Stouffer RL; Burry KA; Gorrill MJ; Lee DM; Patton PE
    Hum Reprod; 2004 Apr; 19(4):822-30. PubMed ID: 15033950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
    Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
    Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease.
    Kierszniewska-Stepień D; Pietras T; Górski P; Stepien H
    Eur Cytokine Netw; 2006 Mar; 17(1):75-9. PubMed ID: 16613766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of soluble vascular endothelial growth factor receptor 1/sFlt1 and low levels of vascular endothelial growth factor in follicular fluid on the day of oocyte retrieval correlate with ovarian hyperstimulation syndrom regardless of the stimulation protocol.
    Jakimiuk AJ; Nowicka MA; Zagozda M; Koziol K; Lewandowski P; Issat T
    J Physiol Pharmacol; 2017 Jun; 68(3):477-484. PubMed ID: 28820403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
    Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
    Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.
    Gómez R; Simón C; Remohí J; Pellicer A
    Biol Reprod; 2003 Jun; 68(6):2164-71. PubMed ID: 12606463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
    Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
    Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
    Zhou C; Yu C; Zhuang G
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
    Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
    Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
    Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
    Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
    Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
    Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
    Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
    Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.